Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAPATINIB DITOSYLATE Cause Movement disorder? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Movement disorder have been filed in association with LAPATINIB DITOSYLATE (Lapatinib). This represents 0.3% of all adverse event reports for LAPATINIB DITOSYLATE.

12
Reports of Movement disorder with LAPATINIB DITOSYLATE
0.3%
of all LAPATINIB DITOSYLATE reports
3
Deaths
5
Hospitalizations

How Dangerous Is Movement disorder From LAPATINIB DITOSYLATE?

Of the 12 reports, 3 (25.0%) resulted in death, 5 (41.7%) required hospitalization, and 1 (8.3%) were considered life-threatening.

Is Movement disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAPATINIB DITOSYLATE. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does LAPATINIB DITOSYLATE Cause?

Diarrhoea (893) Death (665) Nausea (317) Fatigue (301) Vomiting (259) Rash (249) Drug ineffective (183) Malignant neoplasm progression (183) Off label use (141) Disease progression (137)

What Other Drugs Cause Movement disorder?

SECUKINUMAB (788) TOFACITINIB (679) FINGOLIMOD (648) METHOTREXATE (610) PREGABALIN (572) CARBIDOPA\LEVODOPA (545) DALFAMPRIDINE (428) ACETAMINOPHEN\PROPOXYPHENE (399) PROPOXYPHENE (399) ADALIMUMAB (366)

Which LAPATINIB DITOSYLATE Alternatives Have Lower Movement disorder Risk?

LAPATINIB DITOSYLATE vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN LAPATINIB DITOSYLATE vs LARONIDASE LAPATINIB DITOSYLATE vs LAROTRECTINIB LAPATINIB DITOSYLATE vs LASILIX LAPATINIB DITOSYLATE vs LASIX

Related Pages

LAPATINIB DITOSYLATE Full Profile All Movement disorder Reports All Drugs Causing Movement disorder LAPATINIB DITOSYLATE Demographics